Tirzepatide, a weight loss medication, has been shown to significantly reduce systolic blood pressure in obese adults, offering a promising approach to treating and preventing hypertension alongside weight management. The findings from the SURMOUNT-1 study highlight tirzepatide’s potential benefits beyond weight loss, emphasizing the need for additional research on its long-term cardiovascular impacts.
#scitechdaily.com
#scientists-discover-secondary-benefit-of-weight-loss-medication-tirzepatide-lowering-systolic-blood-pressure
SciTechDaily
231 ngày
